Delivery Order SPE2DR25D3109-SPE2DR26FT3ES
Award Date 4/30/26
Potential Completion Date 5/21/26
Potential Value $8.6K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency issued a $8,559.84 delivery order to Amerisourcebergen Drug Corp on April 28, 2026, for Ibrance 100 mg tablets (7-count). Place of performance is Conshohocken, PA. Ultimate completion date is May 19, 2026. The order is firm fixed price with no set-aside. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc. and operates as a pharmaceutical distributor supplying the Department of Defense and federal healthcare systems. The company holds a single-award...
- The Defense Logistics Agency issued a $17,119.68 delivery order to Amerisourcebergen Drug Corp on April 9, 2026, for supply of Ibrance 100 mg tablets under a firm fixed-price contract with completion by April 30, 2026. Place of performance is Conshohocken, PA. The order was issued without set-aside on a competitive basis. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc. and serves as a critical federal pharmaceutical distributor, particularly for military healthcare systems through...
- The Defense Logistics Agency issued an $8,555.21 delivery order to Amerisourcebergen Drug Corp on April 27, 2026, for IBRANCE 125 MG CAPSULE 21S pharmaceutical supply. Place of performance is Conshohocken, PA. The order has a firm fixed-price structure with an ultimate completion date of May 18, 2026. No set-aside was used. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc. and operates as a pharmaceutical distributor supplying brand-name and generic medications, specialty...
- On January 23, 2026, the Defense Logistics Agency awarded a delivery order valued at $8,559.84 to Amerisourcebergen Drug Corp for the supply of Ibrance 100 mg tablets (7-count packages). This is a firm fixed-price, non-set-aside contract with an ultimate completion date of February 13, 2026. Amerisourcebergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs, particularly for military and veteran healthcare...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $8,122.48 on August 12, 2025, for the supply of Ibrance 100 mg tablets (7-unit package). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of September 3, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger...
- The Defense Logistics Agency issued a $8,555.21 delivery order to Amerisourcebergen Drug Corp on March 3, 2026, for Ibrance 125 mg capsule supply (21-count packages), with completion required by March 24, 2026. Place of performance is Conshohocken, PA. The order was priced firm fixed price and carried no set-aside. This delivery order is issued against Amerisourcebergen Drug Corp's parent company Cencora, Inc.'s Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to...
- The Defense Logistics Agency issued a $25,684.23 delivery order to Amerisourcebergen Drug Corp on March 10, 2026, for Ibrance 75 mg tablets (7-count packaging), with a completion date of March 31, 2026. The order is issued under the Defense Logistics Agency Troop Support Medical Indefinite Delivery Contract (valued at up to $999,999,999.00 through December 2026), which provides pharmaceutical and medical supply support to military healthcare programs globally. Place of performance is...
- The Defense Logistics Agency issued an $85,614.10 delivery order to Amerisourcebergen Drug Corp on April 30, 2026, for IBRANCE 75 mg tablets (7-count units), with a ceiling value of $85,614.10 and ultimate completion date of May 21, 2026. Place of performance is Conshohocken, PA. The order is firm fixed price with no set-aside and carries pharmaceutical supply scope typical of Amerisourcebergen's transactional medical delivery orders under DLA Troop Support Medical IDCs. Amerisourcebergen...
- The Defense Logistics Agency awarded a delivery order valued at $17,115.05 to AmerisourceBergen Drug Corp for the supply of Ibrance 100 mg capsules (21-count units) on January 6, 2026, with an ultimate completion date of January 28, 2026. This firm fixed-price, non-set-aside contract is being performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. The delivery order is issued under a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- The Defense Logistics Agency issued a delivery order to Amerisourcebergen Drug Corp on March 31, 2026, for $8,555.21 covering Ibrance 125 mg capsule (21-count units), with an ultimate completion date of April 21, 2026. Place of performance is Conshohocken, PA. The order is issued under firm fixed-price pricing with no set-aside applied. This delivery order calls against Amerisourcebergen Drug Corp's parent IDC with DLA Troop Support Medical, a comprehensive pharmaceutical supply vehicle valued...